Form 4: Elevance Health Director Acquires 218 Phantom Stock Units

Elevance Health Director Amy W. Schulman reported the acquisition of 218 phantom stock units under the company's compensation program.

Summary

• Amy W. Schulman, a Director of Elevance Health, Inc. (ELV), acquired 218 phantom stock units.
• These units were accrued under the Company's Board of Directors Compensation Program.
• The phantom stock units will be payable in Company common stock upon the earlier of five years from the preceding annual meeting or when Ms. Schulman ceases to be a director, unless deferred.
• The transaction date for the acquisition was February 2, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine event, as it signifies a director's increased alignment with shareholder interests through equity compensation.

Positives

• Director Amy W. Schulman increased her beneficial ownership in Elevance Health, aligning her interests with shareholders.
• The acquisition of phantom stock units is part of the company's Board of Directors Compensation Program, indicating a structured approach to director remuneration.

Future Outlook

The phantom stock units are scheduled to be payable in Elevance Health common stock upon the earlier of five years from the preceding annual meeting or when the reporting person ceases to be a director, subject to potential deferral.

Industry Context

StockSavvy.ai notes that director stock awards are a common practice in the healthcare industry, aligning executive and board interests with long-term shareholder value. This transaction reflects a standard compensation mechanism for board members at a major health insurer like Elevance Health.

Comparison to Industry Standards

• Director compensation programs involving equity awards, such as phantom stock units, are standard across large-cap healthcare companies.
• Similar structures are observed at UnitedHealth Group (UNH) and Cigna Group (CI), where a portion of director compensation is often tied to company stock to foster long-term alignment and incentivize performance.
• The specific vesting schedule of five years or cessation of directorship is also a common mechanism to ensure continued commitment.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with long-term shareholder value.
• Director (Amy W. Schulman): Receives equity compensation, increasing her stake in the company.

Next Steps

• The phantom stock units will convert to common stock upon the earlier of five years from the preceding annual meeting or the cessation of the reporting person's directorship.

Key Dates

Recommendation

This Form 4 reports a routine grant of phantom stock units to a director as part of their compensation program. While it indicates alignment of interests, it does not present new material information that would significantly alter the investment thesis for Elevance Health, thus a 'hold' recommendation is maintained.

Keywords

Elevance Health, ELV, Amy W. Schulman, Director, Phantom Stock, Insider Transaction, Compensation Program, Beneficial Ownership